文献速递传染病防控与疫情报告

比色RT-LAMP用于鼻咽拭子或粗唾液样本检测SARS-CoV-2:一项在非洲开展的多国诊断准确性研究

Colorimetric RT-LAMP for SARS-CoV-2 detection from nasopharyngeal swabs or crude saliva: a multicountry diagnostic accuracy study in Africa.
PubMed 文献 · Lancet Glob Health · 2025-01-01

该多国诊断准确性研究评估了比色逆转录环介导等温扩增(RT-LAMP)检测SARS-CoV-2的性能。在非洲七国用鼻咽拭子提取RNA检测,灵敏度89%(95%CI 87-90)、特异度95%(93-96);在另外四国用粗唾液(未提取RNA)检测,灵敏度80%(75-84)、特异度99%(96-100)。作者认为比色RT-LAMP在提取RNA和粗唾液样本中均可靠,粗唾液样本上的可接受性能支持其在资源有限环境中用于疫情监测。

要点

  • 鼻咽拭子提取RNA样本中RT-LAMP灵敏度89%(95%CI 87-90),特异度95%(93-96)。
  • 粗唾液(未提取RNA)样本中RT-LAMP灵敏度80%(75-84),特异度99%(96-100)。
  • 预实验报告RT-LAMP灵敏度87%、特异度98%。

核心结论

  • 比色RT-LAMP是检测提取RNA和粗唾液样本中SARS-CoV-2的可靠方法。
  • 粗唾液样本上可接受的性能支持该方法在资源有限环境中用于高效疫情监测的可扩展性。

研究设计与样本

  • 多国诊断准确性研究,评估RT-LAMP检测不同临床样本中SARS-CoV-2的性能。
  • 预实验在斯洛文尼亚和意大利建立分析性能(检测限)并优化RT-LAMP。
  • 在非洲七国(安哥拉、布基纳法索、科特迪瓦、埃塞俄比亚、塞内加尔、苏丹和津巴布韦)检测鼻咽拭子提取RNA。
  • 在另外四国(喀麦隆、埃塞俄比亚、肯尼亚和尼日利亚)检测粗唾液样本(未提取RNA),同时采集配对鼻咽拭子。
  • 以鼻咽拭子提取RNA的RT-qPCR为金标准参考,各实验室按本室标准诊断流程进行RT-qPCR,RT-LAMP采用标准化方案,唾液检测通过集中试剂分发确保标准化。

主要发现

  • 预实验报告RT-LAMP灵敏度87%、特异度98%。
  • 2021年9月1日至2022年6月30日共采集2774份鼻咽拭子和577份粗唾液样本。
  • 鼻咽拭子提取RNA样本中,RT-LAMP检测SARS-CoV-2的灵敏度为89%(95%CI 87-90),特异度为95%(93-96),参照为各参与实验室所用RT-qPCR标准诊断。
  • 粗唾液(未提取RNA)样本中,RT-LAMP灵敏度为80%(75-84),特异度为99%(96-100),参照为配对鼻咽拭子提取RNA的标准诊断结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reverse-transcription loop-mediated isothermal amplification (RT-LAMP) with colorimetric readout is a rapid, robust, and cost-effective one-step amplification assay that we previously trialled for the identification of SARS-CoV-2 in nasopharyngeal swabs in four countries. Here, we expanded our assessment of RT-LAMP for SARS-CoV-2 detection to several other African countries and evaluated its operational performance with crude saliva as a pragmatic approach for outbreak surveillance and response in resource-limited settings. METHODS: We conducted a multicountry diagnostic accuracy study of RT-LAMP for the detection of SARS-CoV-2 in different types of clinical samples. A preliminary study was conducted in Slovenia and Italy to establish the analytical performance (limit of detection) of RT-LAMP and optimise this assay before its deployment in Africa. Subsequently, we tested RT-LAMP with RNA extracted from nasopharyngeal swabs in seven countries in Africa (Angola, Burkina Faso, Côte d'Ivoire, Ethiopia, Senegal, Sudan, and Zimbabwe), and, in parallel, with crude saliva samples (ie, without RNA extraction) in an additional four countries (Cameroon, Ethiopia, Kenya, and Nigeria; paired nasopharyngeal swabs were collected at the same time). In both contexts, quantitative RT-PCR (RT-qPCR) with RNA extracted from nasopharyngeal swabs was used as the gold-standard benchmarking assay to evaluate performance. For RT-qPCR testing, each laboratory followed their own standard diagnostic procedure, whereas a standardised protocol was used for RT-LAMP. Saliva test standardisation was ensured through centralised reagent distribution. We calculated diagnostic parameters (sensitivity, specificity, and accuracy) using a 2 × 2 contingency table. FINDINGS: The preliminary study reported 87% sensitivity and 98% specificity for RT-LAMP. Between Sept 1, 2021, and June 30, 2022, we collected 2774 nasopharyngeal swabs and 577 crude saliva samples. For RNA extracted from nasopharyngeal swabs, the sensitivity and specificity of RT-LAMP for detection of SARS-CoV-2 (relative to the standard of diagnostics-ie, the RT-qPCR assay used in each participating laboratory) were 89% (95% CI 87-90) and 95% (93-96), respectively. Similarly, RT-LAMP tested on saliva without RNA extraction showed 80% (75-84) sensitivity and 99% (96-100) specificity (relative to the results obtained with the standard of diagnostics for RNA extracted from paired nasopharyngeal samples). INTERPRETATION: Colorimetric RT-LAMP is a reliable assay for SARS-CoV-2 detection in both extracted RNA and crude saliva samples. The demonstrably acceptable performance on crude saliva samples (without RNA extraction) underscores the scalability of this method for efficient outbreak surveillance in resource-limited settings. FUNDING: Gates Foundation.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Šušnjar U, Bitew M, Ayele S, et al. Colorimetric RT-LAMP for SARS-CoV-2 detection from nasopharyngeal swabs or crude saliva: a multicountry diagnostic accuracy study in Africa. Lancet Glob Health. 2025. PMID: 40580991. doi:10.1016/S2214-109X(25)00150-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。